Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lotus Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lotus Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Lotus Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is LTUS. The reporting company's CIK number is 1292087.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $409,170.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-06-28||Jin Liu (Director)||Sale||5,000||.95||4,750|
|2008-01-02||Rothberg Melvin (Director)||Sale||30,000||1.01||30,420|
|2007-08-06||Genesis Technology Group Inc (10% Owner)||Sale||680,000||.55||374,000|
Insider trading activities including stock purchases, stock sales, and option exercises of LTUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lotus Pharmaceuticals, Inc. (symbol LTUS, CIK number 1292087) see the Securities and Exchange Commission (SEC) website.